헬스케어 나노테크놀러지 시장 규모 조사 : 양식별, 적응증별, 용도별, 지역별 예측(2022-2032년)

Global Healthcare Nanotechnology Market is valued approximately at USD 194.73 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.15% over the forecast period 2024-2032. Nanotechnology is the science of materials at the subatomic or molecular level, which involves the use of nanoparticles particles smaller than 100 nanometers. These nanoparticles have substantial potential applications in the healthcare sector, such as imaging agents in imaging methods, new diagnostic tools, bio-implants, tissue engineering, pharmaceuticals, and targeted drug delivery. These nanoparticles are widely used for targeted drug delivery treatments due to their larger surface-to-volume ratio, which allows for higher drug loading compared to macro- and micro-size particles. The advancements in nanotechnology can help improve population health through early diagnosis and disease screening, effective drug delivery mechanisms, and health monitoring. Nanotechnology-driven healthcare services emphasize preventative healthcare management, detecting physical risks and pathogens long before traditional methods and examinations can.

The Global Healthcare Nanotechnology Market is experiencing robust growth driven by rising incidences of cardiovascular, orthopedic, and chronic diseases such as obesity, cancer, kidney disorders, and diabetes. The growing geriatric population and increasing awareness of nanomedicine applications for treating various diseases further propel market growth. Additionally, higher unmet medical needs and increased research funding for nanotechnology in healthcare significantly contribute to market expansion. However, stringent regulations, time-consuming approvals, and high costs associated with nanotechnology-based medical devices hinder market growth. Moreover, the development of newer nanomedicines requires considerable time, which limits market expansion.

The key regions considered for the Global Healthcare Nanotechnology Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is expected to dominate the healthcare nanotechnology market due to its advanced healthcare infrastructure, substantial research funding, and presence of key market players. The Asia-Pacific region is projected to experience the highest growth rate during the forecast period, driven by increasing healthcare investments, rising awareness, and a growing patient population.

Major market players included in this report are:

• Pfizer Inc.
• Celgene Corporation
• Abbott Laboratories
• Taiwan Liposome Company Ltd.
• GE Healthcare
• Johnson & Johnson
• Leadiant Biosciences Inc.
• Sanofi SA
• Merck & Company Inc.
• Luminex Corporation

The detailed segments and sub-segment of the market are explained below:

By Modality

• Treatment
• Diagnostics

By Indication

• Clinical oncology
• Infectious diseases
• Clinical cardiology
• Orthopedics
• Neurology
• Urology
• Ophthalmology
• Immunology
• Others

By Application

• Drug delivery
• Regenerative medicine
• Implants
• Diagnostic
• Imaging
• Vaccines
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Healthcare Nanotechnology Market Executive Summary

• 1.1. Global Healthcare Nanotechnology Market Size & Forecast (2022- 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Modality
  • 1.3.2. By Indication
  • 1.3.3. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Healthcare Nanotechnology Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Healthcare Nanotechnology Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing incidences of chronic diseases
  • 3.1.2. Growth in geriatric population
  • 3.1.3. Rise in research funding
• 3.2. Market Challenges
  • 3.2.1. Stringent regulations and time-consuming approvals
  • 3.2.2. High costs associated with nanotechnology-based medical devices
• 3.3. Market Opportunities
  • 3.3.1. Advancements in nanotechnology
  • 3.3.2. Growing awareness of nanomedicine

Chapter 4. Global Healthcare Nanotechnology Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Healthcare Nanotechnology Market Size & Forecasts by Modality 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Healthcare Nanotechnology Market: Modality Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Treatment
  • 5.2.2. Diagnostics

Chapter 6. Global Healthcare Nanotechnology Market Size & Forecasts by Indication 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Healthcare Nanotechnology Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Clinical oncology
  • 6.2.2. Infectious diseases
  • 6.2.3. Clinical cardiology
  • 6.2.4. Orthopedics
  • 6.2.5. Neurology
  • 6.2.6. Urology
  • 6.2.7. Ophthalmology
  • 6.2.8. Immunology
  • 6.2.9. Others

Chapter 7. Global Healthcare Nanotechnology Market Size & Forecasts by Application 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Healthcare Nanotechnology Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Drug delivery
  • 7.2.2. Regenerative medicine
  • 7.2.3. Implants
  • 7.2.4. Diagnostic
  • 7.2.5. Imaging
  • 7.2.6. Vaccines
  • 7.2.7. Others

Chapter 8. Global Healthcare Nanotechnology Market Size & Forecasts by Region 2022-2032

• 8.1. North America Healthcare Nanotechnology Market
  • 8.1.1. U.S. Healthcare Nanotechnology Market
    • 8.1.1.1. Modality breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Indication breakdown size & forecasts, 2022-2032
    • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Healthcare Nanotechnology Market
• 8.2. Europe Healthcare Nanotechnology Market
  • 8.2.1. U.K. Healthcare Nanotechnology Market
  • 8.2.2. Germany Healthcare Nanotechnology Market
  • 8.2.3. France Healthcare Nanotechnology Market
  • 8.2.4. Spain Healthcare Nanotechnology Market
  • 8.2.5. Italy Healthcare Nanotechnology Market
  • 8.2.6. Rest of Europe Healthcare Nanotechnology Market
• 8.3. Asia-Pacific Healthcare Nanotechnology Market
  • 8.3.1. China Healthcare Nanotechnology Market
  • 8.3.2. India Healthcare Nanotechnology Market
  • 8.3.3. Japan Healthcare Nanotechnology Market
  • 8.3.4. Australia Healthcare Nanotechnology Market
  • 8.3.5. South Korea Healthcare Nanotechnology Market
  • 8.3.6. Rest of Asia Pacific Healthcare Nanotechnology Market
• 8.4. Latin America Healthcare Nanotechnology Market
  • 8.4.1. Brazil Healthcare Nanotechnology Market
  • 8.4.2. Mexico Healthcare Nanotechnology Market
  • 8.4.3. Rest of Latin America Healthcare Nanotechnology Market
• 8.5. Middle East & Africa Healthcare Nanotechnology Market
  • 8.5.1. Saudi Arabia Healthcare Nanotechnology Market
  • 8.5.2. South Africa Healthcare Nanotechnology Market
  • 8.5.3. Rest of Middle East & Africa Healthcare Nanotechnology Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Pfizer Inc.
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Celgene Corporation
  • 9.3.3. Abbott Laboratories
  • 9.3.4. Taiwan Liposome Company Ltd.
  • 9.3.5. GE Healthcare
  • 9.3.6. Johnson & Johnson
  • 9.3.7. Leadiant Biosciences Inc.
  • 9.3.8. Sanofi SA
  • 9.3.9. Merck & Company Inc.
  • 9.3.10. Luminex Corporation

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes